Science Explorer Interactive view Map
Company · Basel · Switzerland

Novartis (Switzerland)

In research, Novartis (Switzerland) stands highest in Medicine (#1,242 of 10,443 worldwide), Health Sciences (#1,759 of 11,982 worldwide) and Life Sciences (#1,199 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Statistics and Probability, Hematology and Genetics — Statistics and Probability is 16.2× its share of world research.

novartis.comROR OpenAlex
World rank, 2022–2025
#2,390
of 28,054 · #660 all time
Rank in Switzerland
#28
of 220
Research works
15k
▼ 20% vs 2013–17
Citations
621k
41.1 per fractional work
Top-10% rate
23.1%
record average 16.5%
Open access
24%
world 28%

What is Novartis (Switzerland) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #1,242 of 10,443 20.8%394 #266
Health SciencesDomain #1,759 of 11,982 20.7%413 #343
Life SciencesDomain #1,199 of 7,800 24.8%225 #304
Biochemistry, Genetics and Molecular BiologyField #1,208 of 3,579 28.7%125 #314
Physical SciencesDomain #4,568 of 12,888 27.2%138 #1321
Molecular BiologySubfield #836 of 2,175 29.3%91 #217
Social SciencesDomain #8,314 of 10,521 23.8%62 —

Each strip is that field’s whole ranked pool, with the notch where Novartis (Switzerland) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Medicine#266 #1,242
  2. Health Sciences#343 #1,759
  3. Life Sciences#304 #1,199
  4. Biochemistry, Genetics and Molecular Biology#314 #1,208
  5. Physical Sciences#1,321 #4,568
  6. Molecular Biology#217 #836
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Novartis (Switzerland) specialise in?

Where its research is concentrated relative to its size: Statistics and Probability takes 16.2× the share of its output that it takes of world research.

  1. Statistics and ProbabilitySubfield · 28.8 works16×
  2. HematologySubfield · 31.8 works13×
  3. GeneticsSubfield · 24.8 works11×
  4. Pharmacology, Toxicology and PharmaceuticsField · 22.3 works7.5×
  5. ImmunologySubfield · 43.3 works7.5×
  6. RheumatologySubfield · 28.6 works7.5×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.45× its world share, 18 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.80× its world share, 125 worksBiochemistry, Geneti…Immunology and Microbiology: 5.45× its world share, 46 worksImmunology and Micro…Neuroscience: 1.04× its world share, 14 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.54× its world share, 22 worksPharmacology, Toxico…Chemical Engineering: 0.36× its world share, 1 worksChemical EngineeringChemistry: 3.06× its world share, 40 worksChemistryComputer Science: 0.32× its world share, 21 worksComputer ScienceEnergy: 0.06× its world share, 0 worksEnergyEngineering: 0.22× its world share, 27 worksEngineeringEnvironmental Science: 0.16× its world share, 7 worksEnvironmental ScienceMaterials Science: 0.38× its world share, 11 worksMaterials ScienceMathematics: 2.97× its world share, 29 worksMathematicsPhysics and Astronomy: 0.07× its world share, 1 worksPhysics and AstronomyDentistry: 0.33× its world share, 1 worksDentistryHealth Professions: 0.63× its world share, 14 worksHealth ProfessionsMedicine: 2.45× its world share, 394 worksMedicineNursing: 0.20× its world share, 1 worksNursingVeterinary: 2.06× its world share, 2 worksVeterinaryArts and Humanities: 0.10× its world share, 2 worksArts and HumanitiesBusiness, Management and Accounting: 0.20× its world share, 5 worksBusiness, Management…Decision Sciences: 0.97× its world share, 8 worksDecision SciencesEconomics, Econometrics and Finance: 1.71× its world share, 31 worksEconomics, Econometr…Psychology: 0.32× its world share, 8 worksPsychologySocial Sciences: 0.07× its world share, 8 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.5×. Every wedge is a field page.

Who are the top researchers at Novartis (Switzerland)?

Ranked on the composite score, Frank Bretz, A. Wettstein and H.M. Widmer lead among researchers whose main affiliation is Novartis (Switzerland).

  1. 1 Frank Bretz Switzerland · #7,942 worldwide 1.8k citations · 53 works
  2. 2 A. Wettstein Switzerland · #13,345 worldwide 443 citations · 69 works
  3. 3 H.M. Widmer Switzerland · #43,112 worldwide 1k citations · 30 works
  4. 4 R. Hess Switzerland · #55,725 worldwide 250 citations · 46 works
  5. 5 Peter Ertl Switzerland · #59,521 worldwide 505 citations · 29 works
  6. 6 Marc de Gasparo Switzerland · #60,144 worldwide 213 citations · 41 works
  7. 7 Doriano Fabbro Switzerland · #60,373 worldwide 353 citations · 50 works
  8. 8 David J. Glass Switzerland · #65,621 worldwide 242 citations · 44 works
  9. 9 Davorka Tomic Switzerland · #82,687 worldwide 199 citations · 27 works
  10. 10 R. Neher Switzerland · #84,447 worldwide 225 citations · 33 works
All ranked researchers at Novartis (Switzerland)

Which keywords describe research at Novartis (Switzerland)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Clinical Trials, Epidemiology, Quality of Life, Biomarkers, Autoantibodies, Medicinal Chemistry and Monoclonal Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation57▲ 3.3×68 topics
  2. Epidemiology56▲ 1.70×89 topics
  3. Quality of Life38▲ 3.2×28 topics
  4. Clinical Trials30▲ 5.4×16 topics
  5. Biomarkers28▲ 4.9×15 topics
  6. Cancer28▲ 2.5×43 topics
  7. Treatment28▲ 2.7×34 topics
  8. Diagnosis26▲ 3.4×25 topics
  9. Autoantibodies23▲ 12×8 topics
  10. Medicinal Chemistry23▲ 9.8×11 topics
  11. Monoclonal Antibodies21▲ 28×3 topics
  12. Prognostic Factors21▲ 5.7×13 topics
  13. Pharmacokinetics20▲ 9.3×6 topics
  14. Cancer Therapy19▲ 3.9×16 topics
  15. Genetics19▲ 3.2×16 topics
  16. Bayesian Methods18▲ 43×2 topics
  17. Economic Evaluation18▲ 17×2 topics
  18. Cost-effectiveness Analysis17▲ 25×1 topic
  19. Health Utility Measures17▲ 25×1 topic
  20. Diagnostic Criteria16▲ 8.8×9 topics
  21. Therapeutic Antibodies16▲ 27×2 topics
  22. Adaptive Designs15▲ 87×1 topic
  23. False Discovery Rate15▲ 87×1 topic
  24. Innate Immunity15▲ 5.5×9 topics
  25. Drug Discovery14▲ 7.6×9 topics
  26. Molecular Docking14▲ 13×4 topics
  27. Mutation14▲ 9.0×5 topics
  28. Glycosylation14▲ 15×3 topics
  29. Drug Target Identification14▲ 17×1 topic
  30. Virtual Screening14▲ 17×1 topic
  31. Cytokines14▲ 5.7×7 topics
  32. Biopharmaceuticals13▲ 31×3 topics
  33. Targeted Therapy13▲ 7.0×5 topics
  34. Cognitive Impairment13▲ 6.2×9 topics
  35. Immunogenicity13▲ 36×3 topics
  36. Immunosuppressive Therapy12▲ 7.4×7 topics
  37. Autoimmune11▲ 28×2 topics
  38. Multiple Sclerosis11▲ 36×1 topic
  39. Neuromyelitis Optica11▲ 36×1 topic
  40. Rituximab11▲ 9.0×4 topics

Which research topics does Novartis (Switzerland) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Statistical Methods in Clinical Trials, Computational Drug Discovery Methods and Multiple Sclerosis Research Studies.

Health Systems, Economic…17Health Systems, Economic Evaluations, Quality of Life: 17 fractional worksStatistical Methods in C…15Statistical Methods in Clinical Trials: 15 fractional worksComputational Drug Disco…14Computational Drug Discovery Methods: 14 fractional worksMultiple Sclerosis Resea…11Multiple Sclerosis Research Studies: 11 fractional worksChronic Myeloid Leukemia Treatments: 10 fractional worksMonoclonal and Polyclonal Antibodies Research: 9 fractional worksRenal Diseases and Glome…8Renal Diseases and Glomerulopathies: 8 fractional worksUrticaria and Related Co…8Urticaria and Related Conditions: 8 fractional worksComplement system in dis…7Complement system in diseases: 7 fractional worksPharmaceutical studies a…7Pharmaceutical studies and practices: 7 fractional works
Economics and EconometricsStatistics and ProbabilityComputational Theory and MathematicsPathology and Forensic Medicine6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 17 works
  2. 2 Statistical Methods in Clinical Trials Statistics and Probability 15 works
  3. 3 Computational Drug Discovery Methods Computational Theory and Mathematics 14 works
  4. 4 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 11 works
  5. 5 Chronic Myeloid Leukemia Treatments Hematology 10 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 9 works
  7. 7 Renal Diseases and Glomerulopathies Nephrology 8 works
  8. 8 Urticaria and Related Conditions Rheumatology 8 works
  9. 9 Complement system in diseases Immunology 7 works
  10. 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 7 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.5%not open75.5%

World: 28% of research is openly available.

with international co-authors35.9%domestic only64.1%

World: 19% is written across borders.

How has Novartis (Switzerland)'s research output changed?

Output in 2018–2022 was 20% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Basel

All research institutions in Basel

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.